132 related articles for article (PubMed ID: 16221230)
1. Urinary ortho-tyrosine excretion in diabetes mellitus and renal failure: evidence for hydroxyl radical production.
Molnár GA; Wagner Z; Markó L; Kó Szegi T; Mohás M; Kocsis B; Matus Z; Wagner L; Tamaskó M; Mazák I; Laczy B; Nagy J; Wittmann I
Kidney Int; 2005 Nov; 68(5):2281-7. PubMed ID: 16221230
[TBL] [Abstract][Full Text] [Related]
2. Association of plasma ortho-tyrosine/para-tyrosine ratio with responsiveness of erythropoiesis-stimulating agent in dialyzed patients.
Kun S; Mikolás E; Molnár GA; Sélley E; Laczy B; Csiky B; Kovács T; Wittmann I
Redox Rep; 2014 Sep; 19(5):190-8. PubMed ID: 24693974
[TBL] [Abstract][Full Text] [Related]
3. Insulin Therapy of Nondiabetic Septic Patients Is Predicted by para-Tyrosine/Phenylalanine Ratio and by Hydroxyl Radical-Derived Products of Phenylalanine.
Kun S; Molnár GA; Sélley E; Szélig L; Bogár L; Csontos C; Miseta A; Wittmann I
Oxid Med Cell Longev; 2015; 2015():839748. PubMed ID: 26576228
[TBL] [Abstract][Full Text] [Related]
4. Accumulation of the hydroxyl free radical markers meta-, ortho-tyrosine and DOPA in cataractous lenses is accompanied by a lower protein and phenylalanine content of the water-soluble phase.
Molnár GA; Nemes V; Biró Z; Ludány A; Wagner Z; Wittmann I
Free Radic Res; 2005 Dec; 39(12):1359-66. PubMed ID: 16298866
[TBL] [Abstract][Full Text] [Related]
5. Urinary epidermal growth factor excretion is correlated to renal function loss per se and not to the degree of diabetic renal failure.
ter Meulen CG; Bilo HJ; van Kamp GJ; Gans RO; Donker AJ
Neth J Med; 1994 Jan; 44(1):12-7. PubMed ID: 8202200
[TBL] [Abstract][Full Text] [Related]
6. Serum omentin-1 levels in diabetic and nondiabetic patients with chronic kidney disease.
Tekce H; Tekce BK; Aktas G; Alcelik A; Sengul E
Exp Clin Endocrinol Diabetes; 2014 Sep; 122(8):451-6. PubMed ID: 24918534
[TBL] [Abstract][Full Text] [Related]
7. Comparison of renal resistive index among patients with Type 2 diabetes with different levels of creatinine clearance and urinary albumin excretion.
Afsar B; Elsurer R
Diabet Med; 2012 Aug; 29(8):1043-6. PubMed ID: 22269249
[TBL] [Abstract][Full Text] [Related]
8. The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy.
Shimoike T; Inoguchi T; Umeda F; Nawata H; Kawano K; Ochi H
Metabolism; 2000 Aug; 49(8):1030-5. PubMed ID: 10954022
[TBL] [Abstract][Full Text] [Related]
9. Renal elimination of sclerostin increases with declining kidney function.
Cejka D; Marculescu R; Kozakowski N; Plischke M; Reiter T; Gessl A; Haas M
J Clin Endocrinol Metab; 2014 Jan; 99(1):248-55. PubMed ID: 24187403
[TBL] [Abstract][Full Text] [Related]
10. Application of antibody array technology in the analysis of urinary cytokine profiles in patients with chronic kidney disease.
Liu BC; Zhang L; Lv LL; Wang YL; Liu DG; Zhang XL
Am J Nephrol; 2006; 26(5):483-90. PubMed ID: 17095863
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and severity of anaemia in patients with type 2 diabetic nephropathy and different degrees of chronic renal insufficiency.
Li Vecchi M; Fuiano G; Francesco M; Mancuso D; Faga T; Sponton A; Provenzano R; Andreucci M; Tozzo C
Nephron Clin Pract; 2007; 105(2):c62-7. PubMed ID: 17135770
[TBL] [Abstract][Full Text] [Related]
12. Urine IgM-excretion as a prognostic marker for progression of type 2 diabetic nephropathy.
Tofik R; Torffvit O; Rippe B; Bakoush O
Diabetes Res Clin Pract; 2012 Jan; 95(1):139-44. PubMed ID: 22078636
[TBL] [Abstract][Full Text] [Related]
13. Effect of losartan on proteinuria and urinary angiotensinogen excretion in non-diabetic patients with chronic kidney disease.
Lee YJ; Cho S; Kim SR; Jang HR; Lee JE; Huh W; Kim DJ; Oh HY; Kim YG
Postgrad Med J; 2011 Oct; 87(1032):664-9. PubMed ID: 21715572
[TBL] [Abstract][Full Text] [Related]
14. Marker of lipid peroxidation related to diabetic nephropathy in Indonesian type 2 diabetes mellitus patients.
Sauriasari R; Andrajati R; Azizahwati ; Dharmeizar ; Saputri DA; Muris RU; Manfaatun A; Amanda OF; Setiawan H; Sakano N; Wang DH; Ogino K
Diabetes Res Clin Pract; 2015 Apr; 108(1):193-200. PubMed ID: 25726335
[TBL] [Abstract][Full Text] [Related]
15. Hydroxyl radical generation in oxygen-treated infants.
Lubec G; Widness JA; Hayde M; Menzel D; Pollak A
Pediatrics; 1997 Oct; 100(4):700-4. PubMed ID: 9310528
[TBL] [Abstract][Full Text] [Related]
16. Diabetes mellitus and CKD awareness: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES).
Whaley-Connell A; Sowers JR; McCullough PA; Roberts T; McFarlane SI; Chen SC; Li S; Wang C; Collins AJ; Bakris GL;
Am J Kidney Dis; 2009 Apr; 53(4 Suppl 4):S11-21. PubMed ID: 19285607
[TBL] [Abstract][Full Text] [Related]
17. Urinary sulphate excretion and progression of diabetic nephropathy in Type 1 diabetes.
Andrésdóttir G; Bakker SJ; Hansen HP; Parving HH; Rossing P
Diabet Med; 2013 May; 30(5):563-6. PubMed ID: 23324103
[TBL] [Abstract][Full Text] [Related]
18. High frequencies of diabetic micro- and macroangiopathies in patients with type 2 diabetes mellitus with decreased estimated glomerular filtration rate and normoalbuminuria.
Ito H; Takeuchi Y; Ishida H; Antoku S; Abe M; Mifune M; Togane M
Nephrol Dial Transplant; 2010 Apr; 25(4):1161-7. PubMed ID: 19892756
[TBL] [Abstract][Full Text] [Related]
19. Urinary excretion of creatol, an in vivo biomarker of hydroxyl radical, in patients with chronic renal failure.
Ienaga K; Nakamura K; Fujisawa T; Fukunaga Y; Nihei H; Narita M; Tomino Y; Sanaka T; Aoyagi K; Nakano K; Koide H
Ren Fail; 2007; 29(3):279-83. PubMed ID: 17497440
[TBL] [Abstract][Full Text] [Related]
20. Urinary PC-1 activity in patients with type 1 diabetes mellitus.
Stefanović V; Rajić M; Antić S; Mitić-Zlatković M; Stojiljković S; Ivić MA; Vlahović P
Ann Clin Biochem; 2003 May; 40(Pt 3):235-8. PubMed ID: 12803834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
